To access publisher's full text version of this article click on the hyperlink at the bottom of the pageCyclosporin A (CyA) is a lipophilic, cyclic polypeptide drug with anti-inflammatory properties. It is used in topical treatment of dry eyes and is now commercially available in oil based surfactant containing eye drops. Surfactants can irritate the eye surface causing burning, itching and irritation of the conjunctiva, and oil-based drops can result in blurred vision. Thus, the aim of this study was to develop surfactant free aqueous 0.05% (w/v) CyA eye drops where the drug is present in an aqueous vehicle containing CyA/cyclodextrin (CyA/CD) nanoparticles. The effects of the natural α-, β- and γ-cyclodextrins (αCD, βCD and γCD), as well ...
To access publisher's full text version of this article click on the hyperlink belowPurpose: Tyrosin...
The physiological protective mechanisms of the eye reduce the bioavailability of topically administe...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
To access publisher's full text version of this article click on the hyperlink belowIt is generally ...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
PURPOSE: The aim of the present study was the in vitro and in vivo evaluation of a novel aqueous for...
To access publisher's full text version of this article click on the hyperlink belowIt is generally ...
International audienceBackground: Cyclosporine A (CsA) has been used as a topical treatment for vari...
To access publisher's full text version of this article. Please click on the hyperlink in Additional...
Ophthalmic drug delivery is an important area of research that aims to improve the efficacy and conv...
Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthal...
To access publisher's full text version of this article click on the hyperlink belowCarbonic anhydra...
Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthal...
To access publisher's full text version of this article click on the hyperlink belowPurpose: Tyrosin...
The physiological protective mechanisms of the eye reduce the bioavailability of topically administe...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
To access publisher's full text version of this article click on the hyperlink belowIt is generally ...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
PURPOSE: The aim of the present study was the in vitro and in vivo evaluation of a novel aqueous for...
To access publisher's full text version of this article click on the hyperlink belowIt is generally ...
International audienceBackground: Cyclosporine A (CsA) has been used as a topical treatment for vari...
To access publisher's full text version of this article. Please click on the hyperlink in Additional...
Ophthalmic drug delivery is an important area of research that aims to improve the efficacy and conv...
Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthal...
To access publisher's full text version of this article click on the hyperlink belowCarbonic anhydra...
Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthal...
To access publisher's full text version of this article click on the hyperlink belowPurpose: Tyrosin...
The physiological protective mechanisms of the eye reduce the bioavailability of topically administe...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...